Pantothenic Acid

Vitamin B5 sits at the center of how your cells turn food into energy, build coenzyme A (a helper molecule the body uses to break down fats and sugars), and run the chemistry that keeps your heart, brain, and kidneys working. Most people never check their level, and standard nutrition panels almost never include it.

Measuring it in urine gives you a snapshot of how much B5 your body has handled in the past day or two. Research increasingly ties low levels to type 2 diabetes, kidney disease, and neurological conditions, making this a useful, if still exploratory, marker for anyone interested in metabolic health.

What This Test Actually Measures

This test quantifies pantothenic acid (vitamin B5) in your urine. Because B5 is water-soluble and excreted largely unchanged, the amount you pass tracks closely with what you have recently eaten or absorbed. A scoping review for the Nordic Nutrition Recommendations concluded that urinary pantothenic acid excretion is considered the most reliable indicator of vitamin B5 status, though no formal cutoffs for deficiency or adequacy have been agreed on internationally.

The connection between what you eat and what shows up in urine is well documented in humans. In free-living elderly Japanese women using 24-hour urine collections, intake and urinary excretion moved together at about r=0.59, a moderate-to-strong link. In Japanese schoolchildren, the correlation was r=0.32, weaker but still statistically significant. In adults, urinary B5 has been a strong reflector of recent intake, and at least one study in adolescents also showed a strong correlation between dietary intake and urinary excretion, so urine is informative across life stages even though some early work suggested blood levels may track intake more closely in younger people.

Why This Is a Research-Grade Marker

Honest framing matters here. Urinary pantothenic acid is primarily a research and pathway marker. Clinical labs do not yet have standardized cutoffs, and a single reading does not place you cleanly into a risk category the way LDL or HbA1c does. The value of this test lies in establishing a baseline, watching how it moves with your diet and health, and exploring whether your levels behave the way the research predicts for someone in your situation.

Type 2 Diabetes and Cardiovascular Risk

One of the clearer disease signals in the human literature is for type 2 diabetes and its complications, though the evidence base remains limited. In a single case-control study of adults with and without diabetes, low plasma pantothenic acid was associated with several-fold higher odds of diabetes and diabetes with cardiovascular disease, depending on obesity status. Pantothenic acid moved opposite to HbA1c and glucose, and in the same direction as HDL. People with diabetes plus cardiovascular disease had the lowest levels of all.

These studies measured plasma rather than urine, so they are evidence about a related but different fraction of the same vitamin. Whether your urinary level tracks the same pattern has not been directly tested in large cohorts. The biological case is the same molecule, but specimen choice matters.

Kidney Disease

Urine metabolomics in people with diabetic kidney disease showed that urinary pantothenic acid and related metabolites were significantly down-regulated, with the pantothenate and coenzyme A pathway flagged as disturbed early in the disease. A separate metabolomic study in systemic lupus erythematosus with kidney involvement also implicated this pathway, though pantothenic acid was not isolated as a stand-alone biomarker.

What this means for you: if you have diabetes or another condition that puts your kidneys at risk, a falling trend in urinary pantothenic acid could signal upstream metabolic stress on the kidneys, alongside more established tests like cystatin C, eGFR, and the urine albumin-to-creatinine ratio.

Neurological Conditions

A systematic review of metabolomics studies in Parkinson disease found pantothenic acid altered, most often reduced, in patients compared with controls, with pathway-level changes in pantothenate and coenzyme A biosynthesis. A separate study found pantothenic acid levels reduced in six brain regions of people with dementia with Lewy bodies, mirroring patterns seen in Alzheimer's disease. These findings come from blood and brain tissue, not urinary measurements, so they should be read as evidence about the broader pantothenate pathway rather than direct proof that your urine level predicts your neurological risk.

Why One Reading Is Not Enough

Urinary B5 is highly responsive to recent intake. That is what makes it informative, but it also means a single value can swing based on what you ate yesterday. The right approach is to treat one reading as a starting point, not a verdict. Get a baseline, then retest in 3 to 6 months if you are making meaningful changes to your diet or supplement regimen, and at least once a year after that to watch your trajectory.

Tracking matters more here than in established markers. Because there are no validated clinical cutoffs, your own pattern over time is the most useful thing you have. A steady downward trend on consistent eating habits is more meaningful than any single number, and so is a clear rise after you add a B5 source.

When Results Can Be Misleading

A handful of factors can shift urinary pantothenic acid without telling you anything useful about your underlying health. Lead with the obvious one: timing of intake. Because urine B5 closely reflects the past day or two, a recent meal high in B5-rich foods, a multivitamin taken that morning, or a stretch of skipped meals can all move the number.

• Recent supplement or food intake: because urinary B5 reflects the past day or two, a multivitamin or B-complex taken in the prior 24 to 48 hours can substantially raise your reading without changing your long-term status.
• Sex and body size: after a multivitamin dose, urinary pantothenic acid was higher in females than males regardless of age, suggesting normal differences in how this vitamin is cleared.
• Fenofibrate and similar fibrates: activation of the PPAR-alpha pathway (a metabolic switch that ramps up fat burning) with fenofibrate caused a large drop in urinary pantothenic acid over 7 to 14 days in healthy adults. The vitamin is being pulled into fatty acid metabolism, not lost from your body, so a low reading on this medication does not necessarily mean deficiency.
• Incomplete urine collection: the most reliable method is a 24-hour collection. Spot samples are easier but more variable, so collection technique should be matched across tests when you are trying to compare results.

What an Unexpected Result Should Prompt

If your urinary pantothenic acid is unexpectedly low, the first move is to retest after standardizing your diet and supplement timing for a few days, ideally with a 24-hour collection. If the low reading persists, look at the bigger metabolic picture: check fasting glucose, HbA1c, lipid panel, and kidney markers like cystatin C, eGFR, and the urine albumin-to-creatinine ratio. The associations with diabetes and kidney disease in the literature mean a persistently low value is most informative when read alongside these companion tests.

If you are taking fenofibrate or another fibrate, expect lower urinary B5 and interpret accordingly. If you are otherwise healthy and the value rises after adding B5-rich foods or a B-complex, that confirms your kidneys and absorption are responding normally. Persistent low readings without an explanation, especially alongside abnormal glucose or kidney markers, are worth discussing with a clinician familiar with metabolic medicine or a registered dietitian.